Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).
Meier CA, Braverman LE, Ebner SA, Veronikis I, Daniels GH, Ross DS, Deraska DJ, Davies TF, Valentine M, DeGroot LJ, et al.
J Clin Endocrinol Metab. 1994 Jan;78(1):188-96.PMID: 8288703 [PubMed - indexed for MEDLINE]Related articles